Valued at $571.0M at its later-stage round, Aug 2025. Nothing has traded since.
- ·The complete investor list: 30 names
- ·Watch Strand Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Strand Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Later Stage VC (Series B) | $153.0M | ▮ | ▮ |
| May 2021 | Later Stage VC | $52.1M | ▮ | ▮ |
| May 2019 | Early Stage VC | $5.9M | ▮ | ▮ |
Membership and data by Private Market View
Strand Therapeutics valuation
Strand Therapeutics was valued at $571 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Strand Therapeutics raised?
Strand Therapeutics has raised $256 million across 3 recorded rounds since 2019. The largest was a $5.9 million early-stage round in May 2019; the most recent was a $153 million Series B in Aug 2025.
Strand Therapeutics has filed 2 Form Ds with the SEC since 2019, most recently in Jul 2021 ($52.1 million sold to 13 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: VeraDermics (NYS: MANE) ($596 million), Superluminal Medicines ($576 million) and Bambusa Therapeutics ($555 million).
How Strand Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Strand Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Strand Therapeutics
- What is Strand Therapeutics worth?
- Strand Therapeutics is valued at $571.0M as of Oct 2026. Valued at $571.0M at its later-stage round, Aug 2025. Nothing has traded since.
- How much has Strand Therapeutics raised?
- Strand Therapeutics has raised $255.6M in total funding across 3 recorded rounds.
- When did Strand Therapeutics last raise?
- Strand Therapeutics last raised in Aug 2025 (Later Stage VC (Series B)), raising $153.0M.